Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of joining the trial
- People who have provided signed and dated written consent to participate, in line with the required guidelines
- People who have been diagnosed with severe, uncontrolled asthma for at least 52 weeks before joining, where "uncontrolled" is measured by a specific asthma symptom score (ACQ-5 score above 1.5), and where "severe" means the asthma requires high-level treatment that either still fails to control symptoms or loses control when treatment is reduced (confirm with trial site for full details on qualifying treatment types)
- People who have at least 52 weeks of medical records available from before joining the trial
Who may not be able to join:
- People who are currently receiving, or have received within the past 52 weeks, any biological (immunobiological) therapy for their asthma
- People who currently have, or have previously had, chronic obstructive pulmonary disease (a long-term lung condition that makes breathing difficult) or idiopathic pulmonary fibrosis (a condition causing scarring in the lungs)
- People who are currently participating in, or have participated in within the past 52 weeks, any other clinical trial
- People who have another health condition that, in the opinion of the trial doctor, would make participation difficult or could affect how the trial results are interpreted
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To characterise the profile of routine therapy used for patients with uncontrolled SA not receiving biological therapy in proportion of patients receiving different classes of drugs will be calculated; To determine the pattern and trends of OCS prescription; To describe clinical and demographic characteristics of patients with uncontrolled SA not receiving biological therapy in Russian Federation mean age at the inclusion into the study will be collected; To describe demographic characteristics of patients with uncontrolled SA not receiving biological therapy in Russian Federation mean age at...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.